SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A minor change in the total revenue was seen in the June 2022 quarter. The total revenue for the quarter stood at Rs. 514.00 millions against Rs. 512.69 millions during year ago period.The Company's Net profit for the June 2022 quarter have declined marginally to Rs. 38.67  millions as against Rs. 53.97 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 64.66 millions from 83.29 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 514.00 512.69 0.26 514.00 512.69 0.26 2196.63 2448.05 -10.27
Other Income 29.80 13.31 123.89 29.80 13.31 123.89 119.93 71.41 67.95
PBIDT 64.66 83.29 -22.37 64.66 83.29 -22.37 314.56 449.80 -30.07
Interest 5.04 1.89 166.67 5.04 1.89 166.67 13.55 2.71 400.00
PBDT 59.62 81.75 -27.07 59.62 81.75 -27.07 301.25 447.39 -32.67
Depreciation 9.95 9.71 2.47 9.95 9.71 2.47 39.48 40.35 -2.16
PBT 49.67 72.04 -31.05 49.67 72.04 -31.05 261.77 407.04 -35.69
TAX 11.00 18.07 -39.13 11.00 18.07 -39.13 63.86 115.32 -44.62
Deferred Tax 0.70 -0.06 -1266.67 0.70 -0.06 -1266.67 1.40 2.31 -39.39
PAT 38.67 53.97 -28.35 38.67 53.97 -28.35 197.91 291.72 -32.16
Equity 940.00 789.95 18.99 940.00 789.95 18.99 862.45 789.95 9.18
PBIDTM(%) 12.58 16.25 -22.57 12.58 16.25 -22.57 14.32 18.37 -22.06

Syncom Formulations Share Price

13.46 -0.43 (-3.10%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×